EMA to organize a multi-stakeholder workshop on psychedelic therapies

Written By Guest User

In response to a letter from a group of cross-party MEPs calling for the EU to act fast on psychedelics, the EMA wrote that there are currently 16 clinical trials with psychedelic compounds in the EU and EMA will be holding a multi-stakeholder workshop on the topic towards the end of 2023.

Read the MEP’s letter to EMA here, the EMA reply here and the associated POLITICO article here.

Guest User
Previous

PAREA speakers at the ECNP New Frontiers meeting on psychedelics
Next

EMCDDA - Technical meeting on the medical uses of psychedelics